Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | |
| Cash Flows From Operating Activities | |
| Net Income | -24,201 |
| Depreciation Amortization | 2,189 |
| Accounts receivable | 17 |
| Other Working Capital | 2,271 |
| Other Operating Activity | 3,727 |
| Operating Cash Flow | $-15,997 |
| Cash Flows From Investing Activities | |
| PPE Investments | -915 |
| Purchase Sale Intangibles | -79 |
| Other Investing Activity | -79 |
| Investing Cash Flow | $-994 |
| Cash Flows From Financing Activities | |
| Debt Issued | 10,000 |
| Common Stock Issued | 45 |
| Other Financing Activity | 9,986 |
| Financing Cash Flow | $20,031 |
| Beginning Cash Position | 6,094 |
| End Cash Position | 9,134 |
| Net Cash Flow | $3,040 |
| Free Cash Flow | |
| Operating Cash Flow | -15,997 |
| Capital Expenditure | -915 |
| Free Cash Flow | -16,912 |